Literature DB >> 10651305

Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

S J Prest1, R C Rees, C Murdoch, J F Marshall, P A Cooper, M Bibby, G Li, S A Ali.   

Abstract

We previously reported that chemotactic cytokines (chemokines) induce the directional migration of cells derived from the breast carcinoma cell line MCF-7 in vitro, however it was apparent that only a small percentage of cells displayed the ability to migrate upon stimulation. In the present study three sub-lines derived from the parental MCF-7 cell line were selected for their ability to migrate in response to MIP-1alpha, MIP-1beta or RANTES across Transwell filters of 8 microm pore size. The first round selection of migratory cells resulted in sub-populations which demonstrated an increased chemotactic response compared with parental cells. Cells migrating to MIP-1beta were subjected to four further rounds of positive or negative selection, resulting in two sub-lines, MCF-7L4 and MCF-7U4 which displayed an increased and decreased chemotactic response respectively to MIP-1alpha MIP-1beta and RANTES. No difference in chemokine receptor RNA message expression between these sub-lines and the parental MCF-7 line were detected, although increased levels of alpha3, alpha6 and alphav integrin sub-units were shown for MCF-7L4 (positively selected sub-line) compared with MCF-7U4 cells. Moreover, the in vivo growth of cells derived from the two MCF-7 sub-lines was inversely correlated with their chemotactic response. The results of this study depict further the inherent heterogeneity in cancer, suggesting that the chemotactic response may influence the migratory traits of sub-populations within the tumour and potentially contribute to their in vivo behavior, growth and survival.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651305     DOI: 10.1023/a:1006657109866

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  42 in total

1.  Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES.

Authors:  C Combadiere; S K Ahuja; H L Tiffany; P M Murphy
Journal:  J Leukoc Biol       Date:  1996-07       Impact factor: 4.962

2.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

3.  Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization.

Authors:  L Geng; S A Ali; J F Marshall; C L Mackay; I R Hart; M Delcommence; C H Streuli; R C Rees
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

4.  Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.

Authors:  K Seibert; S M Shafie; T J Triche; J J Whang-Peng; S J O'Brien; J H Toney; K K Huff; M E Lippman
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

5.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

6.  A synthetic peptide inhibitor for alpha-chemokines inhibits the growth of melanoma cell lines.

Authors:  S Hayashi; A Kurdowska; A B Cohen; M D Stevens; N Fujisawa; E J Miller
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

7.  Structure and functional expression of a human interleukin-8 receptor.

Authors:  W E Holmes; J Lee; W J Kuang; G C Rice; W I Wood
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

8.  The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes.

Authors:  M W Carr; R Alon; T A Springer
Journal:  Immunity       Date:  1996-02       Impact factor: 31.745

9.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

Review 10.  Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.

Authors:  C O Zachariae
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1993
View more
  16 in total

1.  MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

Authors:  Jennifer J Rahn; Jeffrey W Chow; Garnet J Horne; Brian K Mah; Joanne T Emerman; Pat Hoffman; Judith C Hugh
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.

Authors:  V Thewes; R Simon; M Hlevnjak; M Schlotter; P Schroeter; K Schmidt; Y Wu; T Anzeneder; W Wang; P Windisch; M Kirchgäßner; N Melling; N Kneisel; R Büttner; U Deuschle; H P Sinn; A Schneeweiss; S Heck; S Kaulfuss; H Hess-Stumpp; J G Okun; G Sauter; A E Lykkesfeldt; M Zapatka; B Radlwimmer; P Lichter; M Tönjes
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

3.  Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

Authors:  Stacey L Hembruff; Nikki Cheng
Journal:  Cancer Ther       Date:  2009-04-14

4.  Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans.

Authors:  Gali Soria; Yaeli Lebel-Haziv; Marcelo Ehrlich; Tsipi Meshel; Adva Suez; Edward Avezov; Perri Rozenberg; Adit Ben-Baruch
Journal:  Neoplasia       Date:  2012-01       Impact factor: 5.715

Review 5.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

6.  Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.

Authors:  Linda Hughes; Catherine Malone; Saranya Chumsri; Angelika M Burger; Susan McDonnell
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

7.  Cancer cell motility: optimizing spatial search strategies.

Authors:  L Leon Chen; Le Zhang; Jeongah Yoon; Thomas S Deisboeck
Journal:  Biosystems       Date:  2008-11-14       Impact factor: 1.973

8.  Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

Authors:  Muthulekha Swamydas; Krista Ricci; Stephen L Rego; Didier Dréau
Journal:  Cell Adh Migr       Date:  2013-05-24       Impact factor: 3.405

9.  Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer.

Authors:  Marlene Wolf; Ian Clark-Lewis; Caroline Buri; Hanno Langen; Maddalena Lis; Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells.

Authors:  Maitham A Khajah; Sanaa Al Saleh; Princy M Mathew; Yunus A Luqmani
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.